Biosimilar erythropoiesis-stimulating agents and the risk of developing anti-drug antibodies—a systematic review Marianne Heibert ArnlindLinda FryklundGöran Bertilsson Review 21 July 2016 Pages: 1161 - 1169
Statin-induced myopathy in a usual care setting—a prospective observational study of gender differences Ilona SkilvingMats ErikssonMarie-Louise Ovesjö Clinical Trial Open access 02 August 2016 Pages: 1171 - 1176
Risk factors for hypernatremia in patients with short- and long-term tolvaptan treatment Keita HiraiTatsuki ShimomuraKunihiko Itoh Pharmacodynamics 09 July 2016 Pages: 1177 - 1183
Effect of cytochrome P450 2C19 polymorphisms on the clinical outcomes of voriconazole: a systematic review and meta-analysis Xiaofei LiCaiyuan YuHuilin Tang Pharmacogenetics 08 July 2016 Pages: 1185 - 1193
Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis Zhigang ZhaoXingang LiShiqi Peng Pharmacogenetics 23 July 2016 Pages: 1195 - 1204
The P450 oxidoreductase (POR) rs2868177 and cytochrome P450 (CYP) 2B6*6 polymorphisms contribute to the interindividual variability in human CYP2B6 activity Li-chen GaoFang-qun LiuJie Tang Pharmacogenetics 20 July 2016 Pages: 1205 - 1213
Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients Aarthi ManoharanDeepak Gopal ShewadeSurendiran Adithan Pharmacogenetics 20 July 2016 Pages: 1215 - 1220
Levobupivacaine absorption pharmacokinetics with and without epinephrine during TAP block: analysis of doses based on the associated risk of local anaesthetic toxicity P. MirandaM. A. CorvettoL. I. Cortínez Pharmacokinetics and Disposition 14 July 2016 Pages: 1221 - 1227
Evaluating patients’ comprehensibility of a standardized medication plan Lea BotermannKatharina MonzelMartin Schulz Pharmacoepidemiology and Prescription 15 June 2016 Pages: 1229 - 1237
Ibuprofen-associated hypothermia in children: analysis of the Italian spontaneous reporting database Monia DonatiLuca MonacoDomenico Motola Pharmacoepidemiology and Prescription 14 July 2016 Pages: 1239 - 1243
Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders—a pharmacoepidemiological study and clinical implications Arton BaftiuCecilie Johannessen LandmarkPål G. Larsson Pharmacoepidemiology and Prescription 13 July 2016 Pages: 1245 - 1254
Effect of prehospital epinephrine on out-of-hospital cardiac arrest: a report from the national out-of-hospital cardiac arrest data registry in Japan, 2011–2012 Tatsuma FukudaNaoko Ohashi-FukudaNaoki Yahagi Pharmacoepidemiology and Prescription 13 July 2016 Pages: 1255 - 1264
Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study Yaa-Hui DongChia-Hsuin ChangMei-Shu Lai Pharmacoepidemiology and Prescription 22 July 2016 Pages: 1265 - 1273
Do the EMA accelerated assessment procedure and the FDA priority review ensure a therapeutic added value? 2006–2015: a cohort study Denis Boucaud-MaitreJean-Jacques Altman Pharmacoepidemiology and Prescription 29 July 2016 Pages: 1275 - 1281
Prevention of selective outcome reporting: let us start from the beginning Rafael Dal-RéAna Marušić Point of View 02 August 2016 Pages: 1283 - 1288